Sven Mensing

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Ulcerative Colitis

Drug Administration

Cross Sectional

Top Venues

Clinical pharmacology and therapeutics

Clinical drug investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Neha Thakre, Aline Goebel, Insa Winzenborg, Ahmed A Suleiman, Ronilda R D'Cunha, Sven Mensing, Wei Liu, Yinuo Pang
Population Pharmacokinetic and Exposure-Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis. Clinical pharmacology and therapeutics 116 (3) (2024)
Neha Thakre, Aline Goebel, Insa Winzenborg, Ahmed A Suleiman, Ronilda R D'Cunha, Sven Mensing, Wei Liu, Yinuo Pang
Population Pharmacokinetic and Exposure-Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis. Clinical pharmacology and therapeutics (2024)
Kosalaram Goteti, Nathan Hanan, Mindy Magee, Jessica Wojciechowski, Sven Mensing, Bojan Lalovic, Yaming Hang, Alexander Solms, Indrajeet Singh, Rajendra Singh, Theodore Robert Rieger, Jin Y Jin
Opportunities and Challenges of Disease Progression Modeling in Drug Development - An IQ Perspective. Clinical pharmacology and therapeutics (2023)
Kosalaram Goteti, Nathan Hanan, Mindy Magee, Jessica Wojciechowski, Sven Mensing, Bojan Lalovic, Yaming Hang, Alexander Solms, Indrajeet Singh, Rajendra Singh, Theodore Robert Rieger, Jin Y Jin
Opportunities and Challenges of Disease Progression Modeling in Drug Development - An IQ Perspective. Clinical pharmacology and therapeutics (2023)
Mohamed Badawi, Xin Chen, Patrick Marroum, Ahmed A Suleiman, Sven Mensing, Anette Koenigsdorfer, Julia Teresa Schiele, Tammy Palenski, Divya Samineni, David Hoffman, Rajeev M Menon, Ahmed Hamed Salem
Bioavailability Evaluation of Venetoclax Lower-Strength Tablets and Oral Powder Formulations to Establish Interchangeability with the 100 mg Tablet. Clinical drug investigation 42 (8) (2022)